Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Abemaciclib

02 1Acenocoumarol

03 1Acetazolamide

04 1Alendronate Sodium

05 1Aniracetam

06 1Antazoline HCl

07 1Antazoline Mesylate

08 1Antazoline Sulfate

09 1Apixaban

10 1Apremilast

11 1Aripiprazole

12 1Baclofen

13 1Baricitinib

14 1Brexpiprazole

15 1Carbamazepine

16 1Carfilzomib

17 1Carvedilol

18 1Carvedilol Phosphate

19 1Clemastine

20 1Clopamide

21 1Dapagliflozin

22 1Dapagliflozin Propanediol Monohydrate

23 1Denotivir

24 1Elagolix Sodium

25 1Empagliflozin

26 1Enzalutamide

27 1Etodolac

28 1Hydrochlorothiazide

29 1Ibandronate Sodium

30 1Isavuconazonium Sulfate

31 1Lamotrigine

32 1Linagliptin

33 1Molsidomine

34 1Naldemedine

35 1Nefopam Hydrochloride

36 1Opipramol Dihydrochloride

37 1Oxcarbazepine

38 1Ozanimod Hydrochloride

39 1Palbociclib

40 1Pentoxifylline

41 1Phenyl Salicylate

42 1Pimavanserin Tartrate

43 1Piracetam

44 1Risedronate Sodium

45 1Rivaroxaban

46 1Sacubitril-Valsartan

47 1Safinamide Mesylate

48 1Salicylamide

49 1Sildenafil Citrate

50 1Sitagliptin Hydrochloride

51 1Sodium Salicylate

52 1Sulfiram

53 1Tadalafil

54 1Ticagrelor

55 1Tolterodine Tartrate

56 1Topiramate

57 1Trametinib

58 1Undecylenic acid monoethanolamide

59 1Vardenafil Hydrochloride

60 1Vismodegib

61 1Xylometazoline Hydrochloride

62 1Zoledronic Acid

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Polpharma API. European CDMO partner and API manufacturer since 1951. Poland-based CDMO and API producer, delivering products to pharmaceutical companies worldwide. Aiming at the continuous development of Polpharma and caring for the future of patients, business partners and our employees, we are launching a specialized facility for the R&D and Pro...
Polpharma API. European CDMO partner and API manufacturer since 1951. Poland-based CDMO and API producer, delivering products to pharmaceutical companies worldwide. Aiming at the continuous development of Polpharma and caring for the future of patients, business partners and our employees, we are launching a specialized facility for the R&D and Production of HPAPI with an OEL value of 10 ng/m3 (OEB 6). The HP API investment includes separate process laboratories (PDL), analytical laboratories (ADL) with the possibility of performing QC analyses, and a GMP kilo-lab production line with volume up to 1.5 kg with potential volume increase.
Polpharma CB

01

arrow
CPHI Middle east
Not Confirmed

Polpharma

Polpharma API. European CDMO partner and API manufacturer since 1951. Poland-based CDMO and API producer, delivering products to pharmaceutical companies worldwide. Aiming at the continuous development of Polpharma and caring for the future of patients, business partners and our employees, we are launching a specialized facility for the R&D and Production of HPAPI with an OEL value of 10 ng/m3 (OEB 6). The HP API investment includes separate process laboratories (PDL), analytical laboratories (ADL) with the possibility of performing QC analyses, and a GMP kilo-lab production line with volume up to 1.5 kg with potential volume increase.

About the Company : Polpharma API. European CDMO partner and API manufacturer since 1951. Poland-based CDMO and API producer, delivering products to pharmaceutical companies worldwide. Aiming at the continuous deve...

Polpharma CB
Polpharma API. European CDMO partner and API manufacturer since 1951. Poland-based CDMO and API producer, delivering products to pharmaceutical companies worldwide. Aiming at the continuous development of Polpharma and caring for the future of patients, business partners and our employees, we are launching a specialized facility for the R&D and Pro...
Polpharma API. European CDMO partner and API manufacturer since 1951. Poland-based CDMO and API producer, delivering products to pharmaceutical companies worldwide. Aiming at the continuous development of Polpharma and caring for the future of patients, business partners and our employees, we are launching a specialized facility for the R&D and Production of HPAPI with an OEL value of 10 ng/m3 (OEB 6). The HP API investment includes separate process laboratories (PDL), analytical laboratories (ADL) with the possibility of performing QC analyses, and a GMP kilo-lab production line with volume up to 1.5 kg with potential volume increase.
Polpharma CB